Relation between the size of patent foramen ovale and the volume of acute cerebral ischemic lesion in young patients with cryptogenic ischemic stroke.

Cerebral lesion volume Cerebral magnetic resonance Cryptogenic stroke Echocardiographic patent foramen ovale dimensions Patent foramen ovale

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 28 12 2020
accepted: 17 05 2021
pubmed: 30 5 2021
medline: 6 1 2022
entrez: 29 5 2021
Statut: ppublish

Résumé

Patent foramen ovale (PFO) closure is superior to medical therapy alone to prevent stroke recurrence in selected patients. Small cortical infarcts and large right to left shunts seem to identify patients who will benefit most from closure. We aimed to study the correlation between the size of the PFO and the volume of cerebral ischemic lesions in young patients with cryptogenic ischemic stroke. PFO dimensions and acute ischemic lesion volume of 20 patients, aged<55 years, were analyzed with transesophageal echocardiography and brain magnetic resonance imaging, respectively. The association between the volume of ischemic lesions with the length of PFO, maximum separation between septum primum and septum secundum, and the combination of the twos was explored. A direct statistically significant correlation was found between cerebral lesion volume and maximum separation of septum primum and septum secundum (p=0.047). Length of PFO showed a non-significant trend towards an inverse correlation with lesion volume (p=0.603). Multiple linear regression analysis showed that cerebral lesion volume was dependent directly on maximum separation and inversely on length of PFO (regression coeff. -0,837; p= 0.057; 2,536, p=0.006, respectively). These data suggest that even small PFO might be pathogenetic in case of small cerebral infarcts and that large cerebral infarcts might be PFO related if the shunt is large. If confirmed, the combination of detailed characteristics of PFO with the volume of cerebral infarct could be integrated in a new score to select patients who would take real advantage from a percutaneous closure.

Sections du résumé

BACKGROUND BACKGROUND
Patent foramen ovale (PFO) closure is superior to medical therapy alone to prevent stroke recurrence in selected patients. Small cortical infarcts and large right to left shunts seem to identify patients who will benefit most from closure. We aimed to study the correlation between the size of the PFO and the volume of cerebral ischemic lesions in young patients with cryptogenic ischemic stroke.
METHODS METHODS
PFO dimensions and acute ischemic lesion volume of 20 patients, aged<55 years, were analyzed with transesophageal echocardiography and brain magnetic resonance imaging, respectively. The association between the volume of ischemic lesions with the length of PFO, maximum separation between septum primum and septum secundum, and the combination of the twos was explored.
RESULTS RESULTS
A direct statistically significant correlation was found between cerebral lesion volume and maximum separation of septum primum and septum secundum (p=0.047). Length of PFO showed a non-significant trend towards an inverse correlation with lesion volume (p=0.603). Multiple linear regression analysis showed that cerebral lesion volume was dependent directly on maximum separation and inversely on length of PFO (regression coeff. -0,837; p= 0.057; 2,536, p=0.006, respectively).
CONCLUSIONS CONCLUSIONS
These data suggest that even small PFO might be pathogenetic in case of small cerebral infarcts and that large cerebral infarcts might be PFO related if the shunt is large. If confirmed, the combination of detailed characteristics of PFO with the volume of cerebral infarct could be integrated in a new score to select patients who would take real advantage from a percutaneous closure.

Identifiants

pubmed: 34050831
doi: 10.1007/s10072-021-05330-y
pii: 10.1007/s10072-021-05330-y
pmc: PMC8724074
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-458

Informations de copyright

© 2021. The Author(s).

Références

Mattle HP, Meier B, Nedeltchev K (2010) Prevention of stroke in patients with patent foramen ovale. Int J Stroke 5:92–102
doi: 10.1111/j.1747-4949.2010.00413.x
Wiktor DM, Carroll JD (2018) The case for selective patent foramen ovale closure after cryptogenic stroke. Cardiovasc Interv Ther 11:e00415
Pristipino C, Sievert H, D’Ascenzo F et al (2019) European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eurointervention 20:1389–1402
doi: 10.4244/EIJ-D-18-00622
Kim BJ, Sohn H, Sun BJ, Song JK, Kang DW, Kim JS, Kwon SU (2013) Imaging characteristics of ischemic strokes related to patent foramen ovale. Stroke 44:3350–3356
doi: 10.1161/STROKEAHA.113.002459
Jung JM, Lee JL, Kim HJ et al (2013) Patent foramen ovale and infarct volume in cryptogenic stroke. J Stroke Cerebrovasc Dis 22:1399–1404
doi: 10.1016/j.jstrokecerebrovasdis.2013.04.034
Akhondi A, Gevorgyan R, Tseng CH, Slavin L, Dao C, Liebeskind DS, Tobis JM (2010) The association of patent foramen ovale morphology and stroke size in patients with paradoxical embolism. Circ Cardiovasc Interv 3:506–510
doi: 10.1161/CIRCINTERVENTIONS.109.908533
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
doi: 10.1161/01.STR.24.1.35
Saver JL (2016) Cryptogenic Stroke. NEJM 374:2065–2074
doi: 10.1056/NEJMcp1503946
Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 42:954–970
doi: 10.1016/S0735-1097(03)01065-9
Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, di Angelantonio E, di Tullio MR, Lutz JS, Elkind MSV, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619–625
doi: 10.1212/WNL.0b013e3182a08d59
Kent DM, Thaler DE (2011) The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials 12:185
doi: 10.1186/1745-6215-12-185

Auteurs

Federica Benvenuti (F)

NEUROFARBA Department, University of Florence, Florence, Italy.

Francesco Meucci (F)

Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Luisa Vuolo (L)

Neuroradiology Unit, Careggi University Hospital, Florence, Italy.

Rita Nistri (R)

Department of Heart and Vessels, Careggi University Hospital, Florence, Italy.

Giovanni Pracucci (G)

NEUROFARBA Department, University of Florence, Florence, Italy.

Antonella Picchioni (A)

NEUROFARBA Department, University of Florence, Florence, Italy.

Gabriele Venturini (G)

NEUROFARBA Department, University of Florence, Florence, Italy.

Miroslava Stolcova (M)

Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Ylenia Failli (Y)

NEUROFARBA Department, University of Florence, Florence, Italy.

Patrizia Nencini (P)

Stroke Unit, Careggi University Hospital, Florence, Italy.

Carlo Di Mario (C)

Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Cristina Sarti (C)

NEUROFARBA Department, University of Florence, Florence, Italy. cristina.sarti@unifi.it.
Stroke Unit, Careggi University Hospital, Florence, Italy. cristina.sarti@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH